Sharon R. Pine, Ph.D. - Publications

Affiliations: 
2003 New York Medical College, New York, NY, United States 
Area:
Molecular Biology, Oncology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Matloub Y, Gaynon PS, Jayabose S, Bostrom BC, Hunger SP, Angiolillo AL, Devidas M, Linda S, Carroll WL, Winick N, Sather H, Pine SR. Bone Marrow (BM) Minimal Residual Disease (MRD) at End of Induction and Interim Maintenance Is Highly Predictive of Outcome in Children with Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Treated on the Children’s Oncology Group Study 1991 Blood. 112: 701-701. DOI: 10.1182/Blood.V112.11.701.701  0.323
2007 Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 110: 2128-31. PMID 17576817 DOI: 10.1182/Blood-2007-01-069542  0.364
2007 Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Pine S, Sandoval C. A Case of Relapsed Down Syndrome–Associated Acute Megakaryoblastic Leukemia Cured with Non-Myeloablative Chemotherapy Clinical Leukemia. 1: 309-312. DOI: 10.3816/Clk.2007.N.023  0.37
2006 Sandoval C, Pine SR, Druschel C, Jayabose S, Guo Q, Yin C. GATA1 Mutations in Newborns with Down Syndrome. Blood. 108: 641-641. DOI: 10.1182/Blood.V108.11.641.641  0.38
2005 Pine SR, Guo Q, Yin C, Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome. Leukemia Research. 29: 1353-6. PMID 15916804 DOI: 10.1016/J.Leukres.2005.04.007  0.42
2005 Pine SR, Yin C, Matloub YH, Sabaawy HE, Sandoval C, Levendoglu-Tugal O, Ozkaynak MF, Jayabose S. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction. The Journal of Molecular Diagnostics : Jmd. 7: 127-32. PMID 15681484 DOI: 10.1016/S1525-1578(10)60018-9  0.354
2005 Sandoval C, Pine SR, Guo Q, Sastry S, Stewart J, Kronn D, Jayabose S. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature. Pediatric Blood & Cancer. 44: 85-91. PMID 15390279 DOI: 10.1002/Pbc.20161  0.365
2003 Pine SR, Moy FH, Wiemels JL, Gill RK, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C, Jayabose S. Real-time quantitative PCR: standardized detection of minimal residual disease in pediatric acute lymphoblastic leukemia. Polymerase chain reaction. Journal of Pediatric Hematology/Oncology. 25: 103-8. PMID 12571459 DOI: 10.1097/00043426-200302000-00004  0.346
2003 Pine SR, Wiemels JL, Jayabose S, Sandoval C. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leukemia Research. 27: 155-64. PMID 12526921 DOI: 10.1016/S0145-2126(02)00183-2  0.367
2002 Wiemels JL, Leonard BC, Wang Y, Segal MR, Hunger SP, Smith MT, Crouse V, Ma X, Buffler PA, Pine SR. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 99: 15101-6. PMID 12415113 DOI: 10.1073/Pnas.222481199  0.351
Show low-probability matches.